Gentian Diagnostics ASA
OSE:GENT
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| NO |
G
|
Gentian Diagnostics ASA
OSE:GENT
|
684.8m NOK |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.5B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.6B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
790.8B JPY |
Loading...
|
Market Distribution
| Min | -3 145.8% |
| 30th Percentile | 7.6% |
| Median | 38.1% |
| 70th Percentile | 59.8% |
| Max | 1 122% |
Other Profitability Ratios
Gentian Diagnostics ASA
Glance View
Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Gentian Diagnostics ASA is 55.1%, which is above its 3-year median of 51.9%.
Over the last 3 years, Gentian Diagnostics ASA’s Gross Margin has increased from 48.3% to 55.1%. During this period, it reached a low of 28.5% on Dec 31, 2022 and a high of 57.5% on Mar 31, 2025.
